Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
GBCC
Previous Meetings
GBCC Information
Archives
Previous Meetings
Photo Album
Announcement
What’s NEW
Previous Meetings (GBCC 2017)
※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
Day 1, Apr 20 (Thu) Day 2, Apr 21 (Fri) Day 3, Apr 22 (Sat)
07:30-08:10
  • Satellite Symposium 2
      
  • Venue:  
    Halla Hall
  • Dose Intensity and the Importance of Febrile Neutropenia Prevention
    Yeon Hee Park (Samsung Medical Center, Korea)Slide ViewVideo ViewAbstract
08:30-09:30
  • Plenary Lecture 3
      
  • Venue:  
    Halla Hall
09:40-10:50
  • Symposium 2: 
    Immuno-oncology - Where We Are?  
  • Venue:  
    Halla Hall
  • Immune Check-point Blockade for Breast Cancer
    Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom)
  • Immune Approaches to the Treatment of Breast Cancer, around the Corner?
    Yasir Nagarwala (Merck & Co., Inc., U.S.A.)Video ViewAbstract
  • Immune Monitoring for Immuno-oncology Clinical Trials
    Mary L. Disis (Univ. of Washington, U.S.A.)Slide ViewVideo View
  • Invited Oral Presentation
      
  • Venue:  
    Lotus Hall
  • SUBGROUP ANALYSIS OF ASIAN POPULATION AMONG PALOMA-2 TRIALS
    In Hae Park (National Cancer Center, Korea)Abstract
  • FIRST-LINE RIBOCICLIB + LETROZOLE IN POSTMENOPAUSAL ASIAN WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR+), HER2-NEGATIVE (HER2-) ADVANCED BREAST CANCER (ABC): A SUBGROUP ANALYSIS OF MONALEESA-2
    Yoon Sim Yap (National Cancer Centre Singapore, Singapore)Slide ViewVideo ViewAbstract
  • BREAST MRI MONITORING FOR YOUNG BREAST CANCER PATIENTS AFTER BREAST CONSERVATION THERAPY: A MULTICENTER PROSPECTIVE STUDY
    Woo Kyung Moon (Seoul National Univ. Hospital, Korea)Abstract
  • A PROSPECTIVE, RANDOMIZED, MULTICENTER, OPEN-LABEL PHASE III NEOADJUVANT STUDY TO COMPARE CHEMOTHERAPY WITH ENDOCRINE THERAPY IN PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER
    Hee-Jeong Kim (ASAN Medical Center, Korea)Slide ViewVideo ViewAbstract
11:00-12:10
  • Symposium 3: 
    Young Age Session  
  • Venue:  
    Halla Hall
  • Education Session 2: 
    Mutational Landscape and Its Implications for Treatment of Breast Cancer  
  • Venue:  
    Lotus Hall
  • Overcoming Heterogeneity: Single Cell Sequencing of Breast Cancer
    Wonshik Han (Seoul National Univ. Hospital, Korea)Slide ViewVideo ViewAbstract
  • Practical Implications of Next Generation Sequencing in Breast Cancer: Promises and Challenges
    Naoto Ueno (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.)Slide ViewVideo ViewAbstract
  • Molecular Heterogeneity of Triple-negative Breast Cancer
    Katherine A. Hoadley (On behalf of Prof. Charles M. Perou) (Univ. of North Carolina at Chapel Hill, U.S.A.)Slide ViewVideo ViewAbstract
12:10-13:10
  • Satellite Symposium 3
      
  • Venue:  
    Halla Hall
13:30-14:30
  • Plenary Lecture 4
      
  • Venue:  
    Halla Hall
13:30-15:10
  • Nursing Session: 
    Management of Metastatic, Recurrent and Intractable Breast Cancer  
  • Venue:  
    Weolla Room
  • Survivorship Issues of the Metastatic, Recurrent and Intractable Breast Cancer
    Yaelim Lee (Chung-Ang Univ., Korea)Slide ViewAbstract
  • Nursing Care in Bone Metastasis
    Hyejin Cho (Ewha Womans Univ. Mokdong Hospital, Korea)Slide ViewAbstract
  • Nursing Care in Visceral Metastasis
    Seung Hee Seon (Korea Univ. Guro Hospital, Korea)Slide ViewAbstract
  • Specialist Nursing Roles for the Patient with Metastatic, Recurrent and Intractable Breast Cancer
    Su jin Lee (Dankook Univ. Hospital, Korea)Slide ViewAbstract
  • Complementary and Alternative Therapies
    Eun-Young Jun (DaeJeon Univ., Korea)Slide ViewAbstract
14:30-15:50
  • ABRCA & HBOC
      
  • Venue:  
    Lotus Hall
  • Breast Cancer Genetics - How Is It Changing Our Practice
    Ava Kwong (The Univ. of Hong Kong, Hong Kong)Slide ViewVideo ViewAbstract
  • Panel Testing and SNP Testing (Polygenic Risk Score) in Asian Women
    Soo-Hwang Teo (Cancer Research Malaysia, Malaysia)Slide ViewVideo ViewAbstract
  • Breast Cancer Genetics and Cancer Policy
    Steven A Narod (Women's College Research Institute, Women's College Hospital, Dalla Lana School of Public Health, Univ. of Toronto, Canada)Slide ViewVideo ViewAbstract
  • Genetic Susceptibility to Breast Cancer: Roles of High-moderate and Modest-penetrance Alleles
    David Goldgar (Univ. of Utah School of Medicine, U.S.A.)Abstract
14:40-15:50
  • Symposium 4: 
    Challenges in the Implementation of Biosimilar: New Frontiers in Oncology  
  • Venue:  
    Halla Hall
  • Clinical Considerations for the Development of Biosimilars in Oncology
    Chul Kim (Samsung Bioepis Co., Ltd., Korea)Slide ViewVideo ViewAbstract
  • G-CSF (PEG-GCSF) Biosimilar: Clinical Application and Experience
    Fumikata Hara (National Hospital Organization Shikoku Cancer Center, Japan)Slide ViewVideo ViewAbstract
  • Trastuzumab Biosimilar
    Xavier Pivot (Univ. Hospital of Besancon, France)Slide ViewVideo ViewAbstract
16:00-17:10
  • Panel Discussion 3: 
    Minimizing Local Therapy  
  • Venue:  
    Halla Hall
  • Panel Discussion 4: 
    Role of Imaging in the Era of ALND Omitting of N1 Breast Cancer  
  • Venue:  
    Lotus Hall
16:00-17:20
  • ABC Networking Business Meeting
      
  • Venue:  
    Weolla Room
  • ABCN Collaborative Group
    Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
  • ABCN Mentorship
    Tae Hyun Kim (Inje Univ. Busan Paik Hospital, Korea)
  • Wisdom Sharing: Foundation, Establishment, and Development of BIG
    Martine Piccart (Institut Jules Bordet, Belgium)
  • Clinical Trail Collaboration across and beyond Asia-Pacific - Korea
    Seock-Ah Im (Seoul National Univ., Korea)
  • Clinical Trail Collaboration across and beyond Asia-Pacific - Hong Kong
    Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong)
  • Clinical Trail Collaboration across and beyond Asia-Pacific - Japan
    Shinji Ohno (Cancer Institute Hospital, Japan)
  • Clinical Trail Collaboration across and beyond Asia-Pacific - Singapore
    Yoon Sim Yap (National Cancer Centre Singapore, Singapore)
17:30-18:20
  • Satellite Symposium 4
      
  • Venue:  
    Halla Hall
  • Prognostic Diagnosis for HR+/HER2- Early Breast Cancer Patient Based on the Algorithm through the Gene Expression Signature
    Young Kee Shin (Seoul National Univ., Korea)Slide ViewVideo ViewAbstract


Back to Previous Meetings+



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP